Tower Research Capital LLC (Trc) Inovio Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.35 - $0.53 $6,002 - $9,089	-17,150 Reduced 46.65%	19,610 $10,000
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $211 - $322	-556 Reduced 1.49%	36,760 $14,000
Q2 2023 Aug 14, 2023	SELL	$0.39 - $0.94 $11,609 - $27,981	-29,768 Reduced 44.37%	37,316 $16,000
Q1 2023 May 09, 2023	BUY	$0.79 - $1.91 $35,256 - $85,241	44,629 Added 198.75%	67,084 $55,000
Q4 2022 Feb 10, 2023	SELL	$1.41 - $2.5 $150,346 - $266,572	-106,629 Reduced 82.6%	22,455 $35,000
Q3 2022 Nov 10, 2022	BUY	$1.66 - $2.79 $108,085 - $181,662	65,112 Added 101.78%	129,084 $222,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $26,121 - $72,197	18,140 Added 39.58%	63,972 $110,000
Q1 2022 May 12, 2022	SELL	$2.97 - $5.2 $110,564 - $193,580	-37,227 Reduced 44.82%	45,832 $165,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $111,281 - $166,365	22,301 Added 36.7%	83,059 $414,000
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $368,575 - $498,812	51,477 Added 554.65%	60,758 $435,000
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $47,547 - $76,548	-7,632 Reduced 45.13%	9,281 $86,000
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $99,588 - $191,715	11,304 Added 201.53%	16,913 $157,000
Q4 2020 Feb 16, 2021	SELL	$8.5 - $12.85 $351,619 - $531,565	-41,367 Reduced 88.06%	5,609 $50,000
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $234,694 - $663,374	24,524 Added 109.23%	46,976 $545,000
Q2 2020 Aug 13, 2020	BUY	$7.14 - $31.69 $160,307 - $711,503	22,452 New	22,452 $605,000
Q4 2019 Feb 07, 2020	SELL	$1.97 - $3.72 $7,700 - $14,541	-3,909 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$2.05 - $3.02 $3,950 - $5,819	1,927 Added 97.23%	3,909 $8,000
Q2 2019 Aug 13, 2019	BUY	$2.29 - $4.1 $4,538 - $8,126	1,982 New	1,982 $6,000
Q1 2019 May 14, 2019	SELL	$3.34 - $5.1 $1,880 - $2,871	-563 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.89 - $6.11 $2,190 - $3,439	563 New	563 $2,000
Q2 2018 Aug 15, 2018	SELL	$3.88 - $5.16 $53,575 - $71,249	-13,808 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.05 - $5.69 $50,454 - $70,886	12,458 Added 922.81%	13,808 $65,000
Q4 2017 Feb 09, 2018	SELL	$4.13 - $6.68 $26,580 - $42,992	-6,436 Reduced 82.66%	1,350 $6,000
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $41,732 - $49,596	7,786	7,786 $49,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $476M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account